Description
A CDK4 and CaMKII inhibitor (IC50s = 140 and 25 nM, respectively); selective for CDK4 and CaMKII over PKA and PKC (IC50s = >2 and >100 µM, respectively); inhibits replication of HCMV in vitro (IC50 = 200 nM); inhibits proliferation of HCT116 and NCI H460 carcinoma cells in vitro (IC50s = 850 and 590 nM, respectively); inhibits proliferation and induces apoptosis of ECSCs
Formal name: 12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
Synonyms:
Molecular weight: 325.3
CAS: 118458-54-1
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Kinase Inhibitors|CaMKs||Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|CaMK Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases